Cargando…
Proton pump inhibitor: The dual role in gastric cancer
Proton pump inhibitors (PPIs) are one of the most frequently used medications for upper gastrointestinal diseases. However, a number of physicians have raised concern about the serious side effects of long-term use of PPIs, including the development of gastric cancer. Recent epidemiological studies...
Autores principales: | Joo, Moon Kyung, Park, Jong-Jae, Chun, Hoon Jai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6506576/ https://www.ncbi.nlm.nih.gov/pubmed/31114133 http://dx.doi.org/10.3748/wjg.v25.i17.2058 |
Ejemplares similares
-
Rebuilding trust in proton pump inhibitor therapy
por: Turshudzhyan, Alla, et al.
Publicado: (2022) -
Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
por: Rawla, Prashanth, et al.
Publicado: (2018) -
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness
por: Ierardi, Enzo, et al.
Publicado: (2019) -
Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021) -
Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)